NCT05419206View on ClinicalTrials.gov

The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

May 30, 2022

Conditions
COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality
Interventions
DIAGNOSTIC_TEST

CMV DNA analysis

CMV DNA quantitative viral load levels were studied

Trial Locations (1)

Unknown

Hisar Hospital Intercontinental, Istanbul

All Listed Sponsors
lead

Ramazan Gozukucuk

OTHER

NCT05419206 - The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients | Biotech Hunter | Biotech Hunter